Company Filing History:
Years Active: 2010-2012
Title: Ákos Papp: Innovator in PDE10 Inhibitors
Introduction
Ákos Papp is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmacology, particularly in the development of PDE10 inhibitors. With a total of 2 patents, his work focuses on addressing various neurological and psychological disorders.
Latest Patents
Ákos Papp's latest patents include innovative compounds that inhibit PDE10. These compounds have shown potential utility in treating a range of conditions, including psychotic disorders, anxiety, movement disorders, and neurological diseases such as Parkinson's disease, Huntington's disease, and Alzheimer's disease. The patents detail the general structure of these compounds, which may include pharmaceutically acceptable salts, stereoisomers, solvates, or prodrugs. Additionally, the patents describe compositions that combine these compounds with suitable carriers, as well as methods for their use in inhibiting PDE10 in warm-blooded animals.
Career Highlights
Ákos Papp is currently associated with Omeros Corporation, where he continues to advance his research and development efforts. His work has the potential to impact the treatment landscape for various debilitating conditions, showcasing his commitment to innovation in the pharmaceutical industry.
Collaborations
Throughout his career, Ákos has collaborated with esteemed colleagues, including John E Bergmann and Neil S Cutshall. These partnerships have likely contributed to the success and breadth of his research endeavors.
Conclusion
Ákos Papp stands out as a dedicated inventor whose work in PDE10 inhibitors is paving the way for new therapeutic options. His contributions to the field of pharmacology are noteworthy and reflect his commitment to improving patient outcomes.